Treatment Patterns and Prognosis of Patients with Clear Cell Adenocarcinoma of the Cervix: A Population-Based Cohort Study

Medicine, Obstetrics and Gynecology, Oncology,
clear cell adenocarcinoma of the cervix   overall survival   surgery   propensity score matching   SEER database  

Treatment Patterns and Prognosis of Clear Cell Adenocarcinoma of the Cervix: A Research Study Academic Background Cervical cancer ranks as the fourth most common gynecological malignancy globally and the third leading cause of cancer-related mortality in women. Among its subtypes, clear cell adenocarcinoma of the cervix (CCAC) is an extremely rare ...

A 10-Year Mono-Center Study on Patients with Burns ≥70% TBSA: Prediction Model Construction and Multicenter Validation – Retrospective Cohort

Medicine, Emergency Medicine,
70% TBSA   burn injury   Kunshan   major burn injury   nomogram   overall survival   severe burn injury  

Survival Prediction Model Construction and Validation for Patients with Major Burns Background Burns are the sixth leading cause of death from injuries globally, particularly for patients with major burns (≥70% total body surface area, TBSA), who face severe complications and poor prognosis. Despite advancements in burn treatment, there is still a ...

Ide-cel vs Standard Regimens in Triple-Class–Exposed Relapsed and Refractory Multiple Myeloma: Updated KARMMA-3 Analyses

Medicine, Hematology, Oncology, Life Sciences, Immunology,
multiple myeloma   relapsed and refractory   ide-cel   KARMMA-3 trial   CAR-T cell therapy   progression-free survival   overall survival  

Latest Research Report: Idecabtagene Vicleucel (ide-cel) Significantly Extends Progression-Free Survival in Triple-Class Exposed (TCE) Relapsed or Refractory Multiple Myeloma – Results from the KARMMA-3 Clinical Trial Academic Background and Research Question Patients with Multiple Myeloma (MM) often relapse after multiple lines of therapy, with pr...